Reddit Posts
Feetr Data Dump: RDHL NEGG EYPT BETS LSDI WISA
$EYPT 29% short parabolic off positive trial data.
Small Stakes, Big Rewards: Penny Stocks with 300% Upside Potential
A List of Biotech Stocks With Major Price Movement and Continued Upside Potential.
2 “Strong Buy” Penny Stocks With Over 400% Upside on the Horizon
LIVE: CSPR, BTB, CREX, GGPI, DRUG, KERN, EYPT & Other Stocks Analysis. W...
#premarket #watchlist 11/15 $CREX -Merger With Reflect Systems , $CSPR - to Be Acquired by Durational Capital Management, $DRUG - no news, $EYPT - EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy Data from Phase 1... Any trading ideas? Welcome in comments! Also check my app!
Mentions
$EYPT - phase 3 results due in August
LYTENAVA requires frequent intravitreal injections into the eye whereas the current mkt leader is injection every 4–16 weeks, and a new option Duravyu being developed by Eyepoint Inc $EYPT only requires a single injection for long-acting implant/injection with phase 3 trial results due out in August, which treatment would you rather use?
Absolutely! EKSO: Ekso Bionics Holdings, Inc. (EKSO) is currently trading at $0.9785, showing a bearish trend with the RSI indicating oversold conditions (14-day RSI at 38.83). The stock has been under pressure, with the 8-day EMA ($1.0365) and 20-day EMA ($1.0560) both above the current price, suggesting downward momentum. Recent candles show a consistent decline from highs around $1.14, with significant resistance near $1.03. The MACD histogram is slightly positive, but the overall trend remains negative. Given the lack of recent news and low trading volume compared to its 65-day average, expect limited volatility. For today's session, consider shorting EKSO at $0.98, targeting $0.95 as the first target and $0.92 as the second, with a stop loss at $1.01. Confidence in reaching the first target is moderate due to the prevailing bearish sentiment, while the second target carries lower confidence given potential support levels around $0.95. ADTX: Aditxt, Inc. (ADTX) is experiencing significant downward pressure, with the current price at $0.59, well below its 65-day average volume and recent highs. The technical indicators are bearish: the RSI is deeply oversold, suggesting potential for a short-term bounce, but the MACD remains negative, indicating continued downward momentum. The stock has seen a dramatic decline from over $4 in recent weeks, reflecting a loss of investor confidence, possibly due to lack of positive news or fundamental catalysts. Given the broader market's cautious optimism, ADTX appears disconnected, likely due to company-specific issues. For today's session, consider entering a short position around $0.60, with a first target of $0.55 and a second target of $0.50, setting a stop loss at $0.65. Confidence in reaching the first target is high due to prevailing bearish sentiment, while the second target carries moderate confidence, contingent on sustained selling pressure. Traders should remain vigilant for any unexpected news that could impact this volatile stock. EYPT: EyePoint Pharmaceuticals (EYPT) is poised for a potential upward move today, driven by the recent upsized public offering raising $140 million to advance its clinical pipeline, particularly DURAVYU. The stock has shown strong momentum, with the current price of $11.45 above key moving averages (10-day SMA at $10.76 and 20-day EMA at $10.02), indicating bullish sentiment. The RSI levels in the mid-60s suggest the stock is not yet overbought, while the positive MACD histogram supports continued upward momentum. Given the broader market's cautious optimism and EYPT's sector-specific catalysts, an entry around $11.40 could be strategic. Target the first price at $12.00 with a high confidence level due to recent funding news, and a second target at $12.50 with moderate confidence, considering potential resistance. Set a stop loss at $10.80 to manage downside risk amid market volatility. Overall, the technical indicators and recent developments suggest a favorable setup for a long position today. Unfortunately for ATD, we only track NYSE, NASDAQ, and a lot of OTC but more exchanges are coming soon!
EKSO - ADTX - ATD - EYPT Thank you!
EYPT shed 43% yesterday. Looking for a nice bounce back today.
I just wanted to pop in here and thank y'all for helping me turn out a 300% year thanks to finding EYPT at $3.69 last year. Just pulled everything out the other day when it was at $26, which more than made up for the losses in between. (Damn you PBTS!) To be fair, my ultimate profit is only $200 because Fidelity originally offered me a free $50 for a $50 investment and I'm only here because I thought it would be more fun to gamble while I waited for it be transferable. But as an overall percentage? I'm quite pleased with the uneducated and recreational weekend I spent amongst y'all a year ago! Thanks and best of luck to everyone's investments.
EYPT - potential 70% upside. Promising treatment for Wet AMD (Age-Related Macular Degeneration) which us a condition that affects everyone around 40-50 years old and continues to increase in severity with age (the reason why you need reading glasses as you age)
Smart - I wish I would’ve shouted from the rooftops my confidence about EYPT. They are working on treatment for macular deterioration which effects literally EVERYONE (who lives past 40-50). They have promising results and I unfortunately don’t own as many shares as Id like even tho I got in relatively early at about $3.50-4. I have an exit strategy at about $40 but honestly with how broad the market is for their treatment idk if I can ever sell
EYPT, BOIL and MARA puts were my winners of the day
Check this out. Someone keeps trading biotech news before they are announced. Last week I showed that a trader made $500k into $3.5 million in 24 hours before $ABBV announced acquiring $IMGN. Someone then traded 56% OTM $EYPT calls, making a million from 100k in a day. This week, someone made thousands trading $CERE before it was bought by $ABBV. I will find them all.
Okay...the types of companies that recover after a financing tend to be bigger and on stronger footing. Able to raise money with actual brokers not these sleezeballs like Maxim, Roth, H&W Wainwright, Yorkville, Lincoln Park, etc. EYPT is an example of one. Its financing was at $17 and it actual rose to $20. Companies like BETS are dilution scams. Similar to MCOM, GMBL, CEI, PIXY and a host of other shit stocks. It doesn't matter what industry they are in. They exist purely to look to these sleezeball brokers for toxic financing and dilute their stock 4,000% in a year like what BETS did from 10 million to over 400 million in 2023. https://dilutiontracker.com/app/search/bets
Made $80 on EYPT. They had a good jump this morning
Could you send me a DM of ORTEX data for $TIVC. I’ll be renewing my yearly Ortex subscription this January. Thank you! I’ll be adding $EYPT to my watchlist as well 👍
EYPT, HLMN, OPTT, VEEV, i could go on and on with stocks that didnt go down. Look vertical when othere are looking horizontal. whats going on, is HFs and MMs are scrambling for liquidity on their crypto shorts( they are not as smart as they think they are)
Also they missed getting EYPT last week 🙃
EYPT is a great investment. Stop throwing your money at these bad tickers
EYPT - Broke out of a bullish pennant yesterday. At least 50% upside expecting 100%
AMA: I held $EYPT for a month, took profits at 115% just a few days ago, and am now haunted by alerts that can't help but remind me that I could have made well over 200%. :')
Hey /u/XxRuMoNxX - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EYPT. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
$EYPT… again letting you guys know. Lambo gains is almost there. 
$EYPT…people 
EYPT people… 
EYPT. It's a small cap biopharm that actually makes money and has some prospective products in trials.
$EYPT - Anyone have thoughts on this stock? Got in at 3.50 last week
EYPT is up another 10% today, after gaining 30% yesterday. Don't forget who told you about it first
$EYPT I told you all about this yesterday was at 3.70 now it’s 5.30
I am a bot. You submitted a picture of a banned ticker, EYPT. The market cap of EYPT is **129,515,200** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
$EYPT keeps marching north... +18% now. Told you about it yesterday, hope you enjoy the surge.
$EYPT keeps marching north... Told you about it yesterday, hope you enjoyed the surge.
$EYPT is on watch for today -- +8% on a strong price target [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-154832841.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-154832841.html)
EyePoint Pharmaceuticals (EYPT) In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals, with a price target of $25.00. The company’s shares closed last Tuesday at $3.21, close to its 52-week low of $2.19. According to TipRanks.com, **Chen ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -12.3% and a 31.1% success rate.** Chen covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Greenwich LifeSciences, and Aslan Pharmaceuticals.
Guys, EYPT received 1,450% upside from an analyst -- on watch -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-154832841.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-154832841.html)
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EYPT. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
Watching PROG and EYPT